Nichola Cooper

Department of Medicine
Hammersmith Hospital

Presentation(s):

• OC 04.4 - Disease Relapse in immune Thrombotic Thrombocytopenic Purpura and treatment with Anti-CD20 Monoclonal Antibodies – 10-years’ experience from the UK TTP Registry

  Saturday, July 9, 2022
  1:45 PM – 2:00 PM

• PB1204 - Paradigm shift in ITP treatment patterns in the era of the COVID-19 pandemic - opportunity to study real world outcomes from an established platform: Update from UK Adult ITP registry.

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• OC 73.1 - Updated Main Study Period and Long-Term Extension (LTE) Results With Oral Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Immune Thrombocytopenia (ITP)

  Wednesday, July 13, 2022
  10:15 AM – 10:30 AM

• OC 73.3 - Thrombopoietin receptor agonists (TPO-RAs) in older patients with primary immune thrombocytopenia (ITP): effective and safe? Real World Data from the UK adult ITP registry.

  Wednesday, July 13, 2022
  10:45 AM – 11:00 AM